Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders.
Autoantibodies against glutamate receptor δ2 after allogenic stem cell transplantation.
Autologous hematopoietic cell transplantation in multiple sclerosis.
IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases.
Diffusion Weighted Imaging in Acute Attacks of Multiple Sclerosis.
Oligodendrocytes: Functioning in a Delicate Balance Between High Metabolic Requirements and Oxidative Damage.
Improvement of neurological disorders in postmenopausal model rats by administration of royal jelly.
Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis.
Textured and stimulating insoles for balance and gait impairments in patients with multiple sclerosis and Parkinson's disease: A systematic review and meta-analysis.
Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation.
Establishment of a rat model of chronic thoracolumbar cord compression with a flat plastic screw.
Mobitz type I and II atrioventricular blocks during fingolimod therapy.
Effect of oscillating electrical field stimulation on motor function recovery and myelin regeneration after spinal cord injury in rats.
Encephalomyelitis Associated With Dengue Fever.
Arthropathy-related pain in a patient with congenital impairment of pain sensation due to hereditary sensory and autonomic neuropathy type II with a rare mutation in the WNK1/HSN2 gene: a case report.
Increased regional gray matter atrophy and enhanced functional connectivity in male multiple sclerosis patients.
Recombinant Antibody Fragments For Neurodegenerative Diseases.
MRI Patterns of Isolated Lesions in the Medulla Oblongata.
Neurologic syndrome associated with homozygous mutation at MAG sialic acid binding site.
Natalizumab: a new therapy for acute ischemic stroke?
Septin/anillin filaments scaffold central nervous system myelin to accelerate nerve conduction.
INFLIXIMAB THERAPY IN PATIENTS WITH NONINFECTIOUS INTERMEDIATE UVEITIS RESISTANT TO CONVENTIONAL IMMUNOMODULATORY THERAPY.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Significant Functional Improvement in a Person with Multiple Sclerosis Utilizing Dynamic Neuromuscular Stabilization: 1333 June 2, 8: 00 AM - 8: 20 AM.
Drinking away fatigue in multiple sclerosis.

Pages